People
We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.


matthias steger
phd mba
chief executive officer & co-founder

george pavey
chief financial officer (interim)

alicia hegglin
phd mba
chief operating officer

karim allam
chief legal & people officer

bob silverman
chief business officer

christian angermayer
co-founder & chairman of the board

aaron weaver
cfa
member of the board of directors

stephen helliwell
phd
vp discovery biology

patrick schnider
phd
vp medicinal chemistry

prof. manuel serrano
phd
co-founder & scientific advisor - rejuveron senescence therapeutics

timothy cash
phd
co-founder & consultant - rejuveron senescence therapeutics

tristan heintz
phd
head of research - rejuveron vascular therapeutics

vasco ledebur de antas de campos
phd
head of discovery biology - rejuveron vascular therapeutics

chien chi hsiao
head of medicinal chemistry - rejuveron vascular therapeutics

marianna feretzaki
phd
head of discovery biology - rejuveron telomere therapeutics

fedor romanov michailidis
phd
head of medicinal chemistry - rejuveron telomere therapeutics

ryan byrne
phd
pharmaceutical ai lead

pierre-antoine mudry
bba ms
head, corporate finance and investor relations

kara chatelin
accounting officer in finance

joppe nieuwenhuis
phd
innovation scout

daniele lionetti
msc
finance associate

aksana labokha
phd
head of strategic transactions

naffi wade
director compliance & strategic projects

lisa caflisch
lab manager

csaba budai
it operations manager

malaika schroeder
ma
director marketing & communications

peter sandbach
advisor communications

dovaine pavinksnyte
team assistant
prof. hideyuki okano
md phd
member of the scientific advisory board

prof. lee rubin
phd
co-founder - rejuveron vascular therapeutics